Guidance Shares Strategies to Address Transparency and Bias, while Providing Key Considerations and Recommendations on Product Design, Development and Documentation SILVER SPRING, Md., Jan.
The Food and Drug Administration wants the developers of medical devices that rely on artificial intelligence to disclose much more detail about how their devices were developed and tested ...
The AHA’s recently released “Building and Implementing an Artificial Intelligence Action Plan for Health Care” provides a playbook for allocating resources that prioritize patient access, revenue ...